Total Payments
$343,327
2024 Payments
$14,482
Companies
18
Transactions
413
Medicare Patients
420
Medicare Billing
$39,325
Payment Breakdown by Category
Other$293,140 (85.4%)
Consulting$36,225 (10.6%)
Food & Beverage$8,294 (2.4%)
Travel$5,145 (1.5%)
Education$522.81 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $293,140 | 125 | 85.4% |
| Consulting Fee | $36,225 | 17 | 10.6% |
| Food and Beverage | $8,294 | 195 | 2.4% |
| Travel and Lodging | $5,145 | 68 | 1.5% |
| Education | $522.81 | 8 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $187,624 | 173 | $0 (2021) |
| Biogen, Inc. | $66,695 | 80 | $0 (2023) |
| Celgene Corporation | $22,703 | 28 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $17,399 | 25 | $0 (2018) |
| EMD Serono, Inc. | $16,431 | 47 | $0 (2024) |
| TG Therapeutics, Inc. | $14,445 | 14 | $0 (2024) |
| Acorda Therapeutics, Inc | $10,751 | 13 | $0 (2018) |
| Genentech USA, Inc. | $4,350 | 7 | $0 (2020) |
| Greenwich Biosciences, Inc. | $2,286 | 1 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $142.88 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $14,482 | 15 | TG Therapeutics, Inc. ($14,395) |
| 2023 | $259.12 | 5 | Biogen, Inc. ($150.00) |
| 2022 | $150.04 | 6 | Banner Life Sciences, LLC ($42.05) |
| 2021 | $28,947 | 30 | GENZYME CORPORATION ($12,547) |
| 2020 | $45,425 | 43 | Celgene Corporation ($18,157) |
| 2019 | $84,620 | 102 | GENZYME CORPORATION ($55,876) |
| 2018 | $73,726 | 90 | GENZYME CORPORATION ($54,968) |
| 2017 | $95,719 | 122 | GENZYME CORPORATION ($51,647) |
All Payment Transactions
413 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,712.50 | General |
| Category: Immunology | ||||||
| 11/18/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Immunology | ||||||
| 11/12/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $930.00 | General |
| Category: Immunology | ||||||
| 11/12/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $31.24 | General |
| Category: Immunology | ||||||
| 09/18/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,712.50 | General |
| Category: Immunology | ||||||
| 09/18/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Travel and Lodging | In-kind items and services | $814.11 | General |
| Category: Immunology | ||||||
| 09/05/2024 | Abbott Laboratories | — | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: Neuromodulation | ||||||
| 08/26/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: Immunology | ||||||
| 08/21/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Neurology | ||||||
| 07/18/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,712.50 | General |
| Category: Immunology | ||||||
| 05/22/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $930.00 | General |
| Category: Immunology | ||||||
| 05/01/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $45.25 | General |
| 04/17/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: Immunology | ||||||
| 03/05/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $465.00 | General |
| Category: Immunology | ||||||
| 01/11/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Immunology | ||||||
| 12/13/2023 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: Immunology | ||||||
| 09/06/2023 | EMD Serono, Inc. | MAVENCLAD (Drug) | Food and Beverage | Cash or cash equivalent | $37.40 | General |
| Category: Neurology | ||||||
| 07/19/2023 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: Immunology | ||||||
| 06/01/2023 | Biogen, Inc. | TYSABRI (Biological) | Consulting Fee | Cash or cash equivalent | $150.00 | General |
| Category: Neurology | ||||||
| 05/10/2023 | Horizon Therapeutics plc | UPLIZNA (Drug) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: UPLIZNA | ||||||
| 10/05/2022 | Horizon Therapeutics plc | UPLIZNA (Drug) | Food and Beverage | In-kind items and services | $26.82 | General |
| Category: UPLIZNA | ||||||
| 06/01/2022 | Banner Life Sciences, LLC | BAFIERTAM (Drug) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: Immune | ||||||
| 05/19/2022 | Banner Life Sciences, LLC | BAFIERTAM (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: Immune | ||||||
| 03/22/2022 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $37.36 | General |
| 03/10/2022 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 84 | 103 | $29,127 | $8,310 |
| 2022 | 5 | 99 | 116 | $30,886 | $9,136 |
| 2021 | 5 | 127 | 160 | $44,233 | $11,909 |
| 2020 | 3 | 110 | 154 | $41,538 | $9,969 |
Total Patients
420
Total Services
533
Medicare Billing
$39,325
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 43 | 43 | $16,273 | $4,742 | 29.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 30 | 46 | $8,878 | $2,591 | 29.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 11 | 14 | $3,976 | $977.35 | 24.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 32 | 46 | $9,200 | $2,579 | 28.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 19 | 22 | $6,358 | $1,962 | 30.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 15 | 15 | $6,030 | $1,906 | 31.6% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 17 | 17 | $5,202 | $1,640 | 31.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 16 | 16 | $4,096 | $1,049 | 25.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 28 | 42 | $15,176 | $3,195 | 21.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 34 | 47 | $9,419 | $2,615 | 27.8% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 23 | 23 | $7,038 | $2,249 | 32.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 17 | 23 | $6,808 | $2,082 | 30.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Facility | 2021 | 12 | 12 | $3,036 | $889.90 | 29.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 13 | 13 | $2,756 | $878.54 | 31.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 35 | 68 | $21,382 | $3,997 | 18.7% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 21 | 22 | $6,752 | $2,097 | 31.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 40 | 50 | $7,650 | $2,045 | 26.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 14 | 14 | $5,754 | $1,829 | 31.8% |
About Dr. Rene Elkin, MD
Dr. Rene Elkin, MD is a Neurology healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962592378.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rene Elkin, MD has received a total of $343,327 in payments from pharmaceutical and medical device companies, with $14,482 received in 2024. These payments were reported across 413 transactions from 18 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($293,140).
As a Medicare-enrolled provider, Elkin has provided services to 420 Medicare beneficiaries, totaling 533 services with total Medicare billing of $39,325. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Bronx, NY
- Active Since 10/14/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1962592378
Products in Payments
- AUBAGIO (Drug) $166,538
- TYSABRI (Biological) $26,444
- TECFIDERA (Drug) $24,318
- ZEPOSIA (Drug) $22,647
- LEMTRADA (Drug) $17,820
- COPAXONE (Drug) $17,162
- Rebif (Biological) $16,017
- BRIUMVI (Drug) $14,445
- AMPYRA (Drug) $10,751
- OCREVUS (Biological) $4,350
- VUMERITY (Drug) $3,745
- Mavenclad (Biological) $229.70
- ACTIVA (Device) $115.07
- KESIMPTA (Drug) $105.95
- LEMTRADA (Biological) $99.00
- ACTHAR (Biological) $92.83
- UPLIZNA (Drug) $48.80
- BAFIERTAM (Drug) $42.05
- MAVENCLAD (Drug) $37.40
- GILENYA (Drug) $36.93
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Bronx
Richard Lipton, Md, MD
Neurology — Payments: $982,914
Neurology $982,914
Michael Thorpy, Md, MD
Neurology — Payments: $451,587
Neurology $451,587
Jelena Pavlovic, M.d, M.D
Neurology — Payments: $130,235
Neurology $130,235
Dr. Sandeep Gulati, D.o, D.O
Neurology — Payments: $124,853
Neurology $124,853
Dr. Lauren Gluck, Md, MD
Neurology — Payments: $53,848
Neurology $53,848
Christopher Langston
Neurology — Payments: $46,700
Neurology $46,700